Midcareer Award in Translational Immunology of Aging
Midcareer Award in Translational Immunology of Aging
批准号:
8699112
负责人:
Albert C Shaw
金额:
$16.73万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-08-01 至 2017-04-30
关键词:
AffectAgeAgingAmericanAntibody FormationAreaAwardBaby BoomsBiometryClinicalClinical ResearchClinical TrialsCollaborationsCommunicable DiseasesComputational BiologyComputing MethodologiesContractsDataDecision MakingDevelopmentDevelopment PlansDiseaseDoctor of PhilosophyElderlyEnvironmentFeasibility StudiesFundingFutureGene ExpressionGene Expression ProfileGenerationsGeneticGenomeGeriatricsGrantHIV InfectionsHealthHighly Active Antiretroviral TherapyHumanImmuneImmune responseImmune systemImmunologicsImmunologistImmunologyImmunophenotypingImpairmentIndividualInfectionInfectious Diseases ResearchInfluenza vaccinationInternal MedicineLeadMedicineMentorsMid-Career Clinical Scientist Award (K24)Midcareer Investigator Award in Patient-Oriented ResearchModelingMolecular ImmunologyMorbidity - disease rateMusNational Institute of Allergy and Infectious DiseaseNational Institute on AgingNatural ImmunityNursing HomesOrganismOutcomePattern recognition receptorPilot ProjectsPneumoniaPopulationPositioning AttributePreventionResearchResearch PersonnelResearch TrainingRiskRoleSyndromeSystemToll-like receptorsTrainingUnited States National Institutes of HealthUniversitiesVaccinationVaccinesWorkWorld War IIage effectanalytical methodauthoritybasecareercareer developmentcohortdesignexperiencefeedingfrailtyimmunosenescenceimmunosuppressedimprovedinfluenza virus vaccineinnate immune functioninterestmedical schoolsmembermortalitymulti-component interventionnext generationoral careoral microbiomepatient oriented researchprofessorprogramsreceptorreceptor functionresponsesuccess
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): This application for a K24 Midcareer Investigator Award in Patient-Oriented Research is intended to promote mentoring activities and career development focused on the immunology of aging. Notably, no other currently funded K24 at the NIA is devoted to translational immunology. The PI, Dr. Shaw, is Associate Professor of Medicine at the Yale School of Medicine; he is trained in Internal Medicine and Infectious Disease, and in addition has a Ph.D. in Genetics and is a trained immunologist. Dr. Shaw is recognized as an authority on the aging of the human immune system; his lab has a special interest in aging of the innate immune system, and has carried out the largest and most comprehensive studies to date of the consequences of aging on human Toll-like Receptor (TLR) function. These studies defined features of immunosenescence in the innate immune system, and also demonstrated the linkage between TLR function and adaptive immune responses such as antibody response to influenza vaccine. Although Dr. Shaw has mentored several young investigators who remain in academic research positions, at present his mentoring activities must compete with administrative, clinical and research commitments. In this regard, he is at an ideal point in his career to expand his mentoring activities through the K24 mechanism. Dr. Shaw has recently begun two newly funded projects in patient- oriented research-in the first, he serves as Project Leader for an NIAID contract focusing on understanding age-associated alterations in innate immune pattern recognition receptor function. In the second, he is the PI of an R01 within a U19 Center Grant that is part of the NIH Human Immunophenotyping Consortium. This project will elucidate immunologic and gene expression signatures of influenza vaccine response, and will determine how aging and frailty affect these signatures. These two initiatives form the platform for development of a mentoring and career development plan directed to developing new investigators studying the immunology of aging. In addition, two additional projects would be directly supported by this application: the first, a pilot study of innate immune function in young and older individuals with HIV infection. The second exploratory project leverages an ongoing NIA-sponsored clinical trial at Yale of a multicomponent intervention of upright feeding position and enhanced oral care on nursing home pneumonia prevention. We will evaluate the relationship between innate immune function and results of an ongoing substudy on alterations in oral microbiome composition with enhanced oral care. This research platform will be supported by career development activities that include tutorials in clinical geriatrics, computational biology, and gerontologic biostatistic. Taken together, this program will further enhance the PI's role as a mentor to the next generation of investigators who will advance our understanding of human immunology in the context of aging.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Core D: Clinical Recruitment
-
批准号:10317019
-
项目类别:
-
资助金额:$64.28万
-
财政年份:2020
-
负责人:Albert C Shaw
-
依托单位:
Midcareer Award in Translational Immunology of Aging
-
批准号:10161669
-
项目类别:
-
资助金额:$18.76万
-
财政年份:2012
-
负责人:Albert C Shaw
-
依托单位:
Midcareer Award in Translational Immunology of Aging
-
批准号:9759735
-
项目类别:
-
资助金额:$18.76万
-
财政年份:2012
-
负责人:Albert C Shaw
-
依托单位:
Midcareer Award in Translational Immunology of Aging
-
批准号:8515284
-
项目类别:
-
资助金额:$16.73万
-
财政年份:2012
-
负责人:Albert C Shaw
-
依托单位:
Midcareer Award in Translational Immunology of Aging
-
批准号:10436887
-
项目类别:
-
资助金额:$18.76万
-
财政年份:2012
-
负责人:Albert C Shaw
-
依托单位:
Midcareer Award in Translational Immunology of Aging
-
批准号:8354266
-
项目类别:
-
资助金额:$16.73万
-
财政年份:2012
-
负责人:Albert C Shaw
-
依托单位:
Immune responses defining efficiency of influenza vaccination
-
批准号:8307054
-
项目类别:
-
资助金额:$43.19万
-
财政年份:2011
-
负责人:Albert C Shaw
-
依托单位:
Systems investigation of vaccine responses in aging and frailty
-
批准号:10617768
-
项目类别:
-
资助金额:$47.98万
-
财政年份:2010
-
负责人:Albert C Shaw
-
依托单位:
Core D: Clinical Recruitment
-
批准号:10079823
-
项目类别:
-
资助金额:$15.92万
-
财政年份:2010
-
负责人:Albert C Shaw
-
依托单位:
Systems investigation of vaccine responses in aging and frailty
-
批准号:10420327
-
项目类别:
-
资助金额:$34.54万
-
财政年份:2010
-
负责人:Albert C Shaw
-
依托单位:
Clinical subjects and recruitment
-
批准号:10617753
-
项目类别:
-
资助金额:$20.23万
-
财政年份:2010
-
负责人:Albert C Shaw
-
依托单位:
Clinical subjects and recruitment
-
批准号:10420324
-
项目类别:
-
资助金额:$34.54万
-
财政年份:2010
-
负责人:Albert C Shaw
-
依托单位:
Project 3: Effects of Age on Cellular, Transcriptomic and Biochemical Influenza Signatures
-
批准号:10079825
-
项目类别:
-
资助金额:$38.53万
-
财政年份:2010
-
负责人:Albert C Shaw
-
依托单位:
Top3 Homologues in Lymphocyte Genome Stability and Aging
-
批准号:7459678
-
项目类别:
-
资助金额:$26.59万
-
财政年份:2005
-
负责人:Albert C Shaw
-
依托单位:
Top3 Homologues in Lymphocyte Genome Stability and Aging
-
批准号:7097273
-
项目类别:
-
资助金额:$27.94万
-
财政年份:2005
-
负责人:Albert C Shaw
-
依托单位:
Top3 Homologues in Lymphocyte Genome Stability and Aging
-
批准号:7261905
-
项目类别:
-
资助金额:$27.13万
-
财政年份:2005
-
负责人:Albert C Shaw
-
依托单位:
Top3 Homologues in Lymphocyte Genome Stability and Aging
-
批准号:6969008
-
项目类别:
-
资助金额:$27.34万
-
财政年份:2005
-
负责人:Albert C Shaw
-
依托单位:
Top3 Homologues in Lymphocyte Genome Stability and Aging
-
批准号:7640925
-
项目类别:
-
资助金额:$26.59万
-
财政年份:2005
-
负责人:Albert C Shaw
-
依托单位:
Core 003 - Pilot Exploratory Studies Core
-
批准号:10728898
-
项目类别:
-
资助金额:$28.5万
-
财政年份:2002
-
负责人:Albert C Shaw
-
依托单位:
Pilot and Exploratory Studies Core
-
批准号:10202428
-
项目类别:
-
资助金额:$22.0万
-
财政年份:2002
-
负责人:Albert C Shaw
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: